Florent, C <br/><br/>
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Mar 1996 
 - 229-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-691X 
<br/><br/><label>Standard No.: </label>10.1097/00042737-199603000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aged<br/>Aminosalicylic Acids--administration & dosage<br/>Anastomosis, Surgical<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Chemoprevention<br/>Colonic Diseases--pathology<br/>Colonoscopy<br/>Constriction, Pathologic--pathology<br/>Crohn Disease--pathology<br/>Double-Blind Method<br/>Drug Tolerance<br/>Female<br/>Humans<br/>Ileal Diseases--pathology<br/>Male<br/>Mesalamine<br/>Middle Aged<br/>Placebos<br/>Recurrence<br/>Ulcer--pathology